Pro Medicus Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pro Medicus Ltd (PME)
Track today's live Pro Medicus Ltd (PME) share price, performance and key data on this page with our current Sydney:PME stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Pro Medicus Ltd share price on the Sydney exchange. Use the dropdown to switch exchange for the PME share price, head to our technical summary section, which provides analysis on Pro Medicus Ltd share price buy/sell indicators using real-time data (or discuss the Pro Medicus Ltd (PME) stock price today with other investors in the Pro Medicus Ltd ASX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ASX:PME share price (ISIN: AU000000PME8) to enhance your trading decisions with our free investment tools and resources.
What Is the Pro Medicus Ltd Share Price Today?
The Pro Medicus Ltd share price today is 209.65.
What Is the Stock Symbol for Pro Medicus Ltd
The stock symbol (or 'ticker') for Pro Medicus Ltd is "PME."
What Stock Exchange Does Pro Medicus Ltd Trade On?
Pro Medicus Ltd is listed and trades on the Sydney stock exchange.
Is Pro Medicus Ltd a Good Stock to Buy?
Determining whether Pro Medicus Ltd (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current ASX:PME share price (ISIN: AU000000PME8) to enhance your trading decisions with our free investment tools and resources.
What Is the Pro Medicus Ltd Share Price Today?
The Pro Medicus Ltd share price today is 209.65.
What Is the Stock Symbol for Pro Medicus Ltd
The stock symbol (or 'ticker') for Pro Medicus Ltd is "PME."
What Stock Exchange Does Pro Medicus Ltd Trade On?
Pro Medicus Ltd is listed and trades on the Sydney stock exchange.
Is Pro Medicus Ltd a Good Stock to Buy?
Determining whether Pro Medicus Ltd (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
209.65
+3.72(+1.81%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
202.01
212.30
52 wk Range
107.75
336.00
PME is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
202.01212.30
52 wk Range
107.75336.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.30%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.30%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PME Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
181.44
Downside
-13.46%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
- Pro Medicus Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Pro Medicus Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Pro Medicus Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Pro Medicus Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Pro Medicus Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
12 Buy
2 Hold
1 Sell
Ratings:
15 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 181.44
(-13.46% Downside)
Pro Medicus Ltd Earnings Call Summary for H1/2026
- Pro Medicus reported record H1 2026 performance with 28.4% revenue growth and ~30% increase in underlying EBIT, though stock fell 19.71% post-announcement.
- Interim dividend increased by 28% to AUD 0.32 per share, fully franked, with cash and investments up 5.3%.
- Company launched new cardiology suite, expanded AI capabilities, and is developing digital pathology products as part of its enterprise imaging strategy.
- CEO Dr. Sam Hupert projects forward revenue to exceed AUD 1 billion over next five years, with expectations for stronger H2 FY2026 performance.
- Management views AI integration as 'a plus rather than a threat,' focusing on both proprietary AI development and strategic third-party partnerships.
Last Updated: 12/02/2026, 01:42
Read Full TranscriptEarnings
Latest Release
03/06/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare PME to Peers and Sector
Metrics to compare | PME | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPMEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 93.3x | 17.2x | −0.4x | |
PEG Ratio | 0.67 | 0.12 | 0.00 | |
Price/Book | 56.3x | 1.8x | 2.6x | |
Price / LTM Sales | 91.0x | 1.6x | 3.1x | |
Upside (Analyst Target) | −6.0% | 15.9% | 48.8% | |
Fair Value Upside | Unlock | 12.2% | 6.3% | Unlock |
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease, a mobile application that provides users access to medical imaging results; and Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Pro Medicus Ltd (Sydney: PME) Share Price Today?
The Pro Medicus Ltd stock price today is 209.65 AUD.
What Stock Exchange Does Pro Medicus Ltd (PME) Trade On?
Pro Medicus Ltd is listed and trades on the Sydney Stock Exchange.
What Is the Ticker (Stock Symbol) for Pro Medicus Ltd?
The stock symbol (also called a 'ticker') for Pro Medicus Ltd is "PME."
Does Pro Medicus Ltd Pay Dividends? What’s The Current PME Dividend Yield?
Yes, PME Pays Dividends to its Shareholders. The current Pro Medicus Ltd dividend yield is 0.3%.
What Is the Current Pro Medicus Ltd Market Capitalisation?
As of today, Pro Medicus Ltd (Sydney: PME) market cap is 21.90B AUD.
What Is Pro Medicus Ltd's (PME) Earnings Per Share (TTM)?
The Pro Medicus Ltd EPS is currently 2.24 (Trailing Twelve Months).
When Is the Next Pro Medicus Ltd Earnings Date?
Pro Medicus Ltd's next earnings report will be released on 19/08/2026.
Is PME a Buy or Sell From a Technical Analyst Perspective?
Based on today's Pro Medicus Ltd moving averages and other technical indicators, the daily buy/sell signal for PME stock is Strong Buy.
How Many Times Has Pro Medicus Ltd Stock Split?
Pro Medicus Ltd has split 0 times. (See the PME stock split history page for full effective split date and price information.)
How Many Employees Does Pro Medicus Ltd Have?
Pro Medicus Ltd has 132 employees, based on their latest Companies House report.
What is the current trading status of Pro Medicus Ltd (Sydney: PME)?
As of 05/07/2026, Pro Medicus Ltd (PME) is trading at a share price of 209.65 AUD, with a previous close of 209.65 AUD. The stock has fluctuated within a day range of 202.01 AUD to 212.30 AUD, while its 52-week range spans from 107.75 AUD to 336.00 AUD.
What Is Pro Medicus Ltd (PME) Price Target According to Analysts?
The average 12-month price target for Pro Medicus Ltd is 181.44 AUD, with a high estimate of 240 AUD and a low estimate of 54 AUD. 12 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an -13.46% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.